Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-EN Version v9-EN
Language English English
Date Updated 2022-04-05 2022-03-03
Drug Identification Number 02231674 02231674
Brand name PROTAMINE SULFATE INJECTION USP PROTAMINE SULFATE INJECTION USP
Common or Proper name PROTAMINE SULFATE INJECTION USP PROTAMINE SULFATE INJECTION USP
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients PROTAMINE SULFATE PROTAMINE SULFATE
Strength(s) 10MG 10MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 25ML 1LIVI CA 25ML 1LIVI CA
ATC code V03AB V03AB
ATC description ALL OTHER THERAPEUTIC PRODUCTS ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-04-23 2021-04-23
Estimated end date Unknown 2022-07-22
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments